Thus, thyroid carcinomas maintain low D6/ACKR2 levels to sustain chemokine trafficking inside tumor microenvironment and to ensure tumor progression driven by the pro-oncogenic activity of recruited inflammatory cells. Here, ACKR2 is linked to neoplasm.